Dr. Seon-Kyu Lee of Montefiore Health System is a 2025 Brain Aneurysm Foundation research grant recipient. Supported by Froggy’s Drive and Sharon Epperson Chairs of Research, he’s using AI to untangle complex immune responses in post-aneurysm care and uncover new treatment targets. Learn more about him here, https://lnkd.in/eKYjZaGm

How do you treat diseases in a place the body is designed to protect? The brain is notoriously hard to reach, but our scientists are breaking through. By leveraging the body’s own transport systems, we are mastering the art of carrying therapies across the blood-brain barrier, paving the way for effective treatments for a range of rare neurological diseases. In part 2 of our series, Global Head of Rare and Neurological Diseases, Pablo Sardi, confidently shares how we’re harnessing AI and innovative delivery platforms to redefine the approach for some of the world’s most challenging conditions. Learn more in our latest article: http://spkl.io/6043AVr47 #RareDisease #Immunoscience #WeNeverSettle #sanofistories

Discover the alarming truth behind Alzheimer's: over 55 million affected worldwide, with an impending rise to 140 million by 2050. Join us as we dive into AI's role in tackling this global crisis with Ira Haraldson, the brain behind the AI Mind Project. Don't miss this eye-opening conversation on the future of brain health! Ira Hebold Haraldsen [https://lnkd.in/gvrFA4tJ]  iraharaldsen [https://lnkd.in/guzXKz62]

With advances in brain-computer interfaces, University of California researchers are restoring strength, voice, sight, and independence to people with degenerative diseases or paralysis. https://bit.ly/4mrUK5E

Excited to announce that my research paper ‘Harnessing Machine Learning to Forecast Cardiovascular Disease Risk with Explainable AI’ has been published! This work highlights how machine learning, combined with explainable AI, can provide valuable insights into cardiovascular health. #MachineLearning #ExplainableAI #IEEE #Research #HealthcareAI #CVD 🔗 Read more here: https://lnkd.in/d8WR2nVg https://lnkd.in/gQCZ9Fbn

Innovators in AI: spotlight on Brainomix 🧠 Over 17,000 stroke cases have been screened since Wales launched its national rollout to improve stroke care. Brainomix’s AI-powered platform is accelerating diagnosis, improving access to life-saving thrombectomy procedures, and helping Wales improve treatment rates. Our latest guest blog by Riaz Rahman and Dr Shakeel Ahmad, explores how AI is reshaping clinical pathways and what’s next for stroke innovation in Wales. Read the blog in full: https://lnkd.in/eBPY44KY #AIinHealthcare #StrokeInnovation #Brainomix #Stroke #DigitalHealth

We are proud to partner with NHS Wales to power stroke care across the entire nation. Since the national rollout of Brainomix 360 Stroke, over 17,000 stroke cases have been scanned, and thrombectomy and thrombolysis rates have nearly doubled. All of this leading to faster, more accurate diagnoses and significantly improved treatment rates for patients across Wales.   Click the article to read about the positive impact that Brainomix has had since the national rollout this past year, with insights from Riaz Rahman and Dr Shakeel Ahmad.   #TransformingTreatment #AIinHealthcare #Brainomix #DigitalHealth #StrokeCare

Real-world evidence on how AI in medical imaging saves life, from Wales! This is not anecdotal: more than 17,000 patients scanned and precisely diagnosed & 'triaged' to the right treatment to save their brains and their life, in acute care, in less than a year. This is why Stroke AI matters!!!

The deployment of Brainomix 360 Stroke AI across Wales is one of three successful national collaborations including Hungary and Poland. We are indebted to the excellent team at NHS Wales to help make our joint vision a reality with measurable impact of life saving treatment rates. Mark Drakeford, Cabinet Secretary for Health and Social Care “Time is critical in stroke care, so I’m delighted to see this new technology go live which helps clinicians evaluate the severity of strokes and quickly identify appropriate treatments. “This is one of a number of exciting digital innovations being adopted in Wales to improve stroke care and will significantly improve the thrombectomy rate and outcomes for stroke patients. “I would like to thank everyone involved for their commitment and passion in getting this AI stroke imaging rolled out across Wales." George Harston Edwin Heisterkamp Mark Drakeford Anthony Dooher https://lnkd.in/dfPdYY52

Today, the Diagnostics Accelerator (DxA) announced two major milestones: the release of SpeechDx’s first tranche of data and a new partnership with Callyope, expanding the ecosystem advancing speech-based diagnostics. Callyope is the second partner to license the dataset. By leveraging #SpeechDx data to train and validate its AI speech-foundation model, Callyope can accelerate the development of tools for mental health and neurodegenerative diseases, including #Alzheimer’s and #Parkinson’s. Through harnessing the power of #AI, SpeechDx is creating reliable, affordable diagnostic tools, a foundational goal of DxA. This gold standard dataset will power a new generation of AI tools to forecast Alzheimer’s risk, track progression, and guide interventions before symptoms appear – paving the way for precision medicine. https://lnkd.in/ebRdX-xz